This article briefly discusses eleven different healthcare and business issues. We have divided the article the letter into three key sections. The first focuses on hospital and physician issues. Second, a brief observation on urgent care and sleep labs. Third,…
The Latest
A study found adding the chemotherapy drug oxaliplatin to 5-fluorouracil during adjuvant treatment for stage III colon cancer improved survival in the general patient population, according to findings published in the Journal of the National Cancer Institute.
Greg Zoch, partner and managing director at Kaye/Bassman International Corp., an executive search firm specializing in the ambulatory surgery center industry, discusses five traits he identifies as characteristic of successful ambulatory surgery center directors of nursing.
The Maryland Department of Health and Mental Hygiene has launched a new website that categorizes healthcare innovations by clinical innovations, financial mechanisms and integrated programs.
The National Quality Forum has endorsed 64 measures that cover patient safety, cardiovascular care and other aspects of patient care, including 21 time-limited endorsed measures focused on patient safety, surgical care, infectious disease, healthcare systems and cancer care.
A review of the National Quality Forum's activities revealed that although the group completed or made progress on a majority of its projects, NQF did not meet or did not expect to meet the initial time frames approved by HHS…
The Accreditation Association for Ambulatory Health Care has issued an alert to California surgery centers regarding changes to the accreditation process.
The Association for Professionals in Infection Control and Epidemiology has launched a complete redesign of its main website, www.apic.org, according to an APIC release.
Federal regulators have accepted a corrective action plan to fix telemetry deficiencies at Cape Fear Valley Health System in Fayetteville, N.C., allowing the health system to keep its Medicare funding, according to a WRAL report.
Researchers from Memorial Sloan-Kettering Cancer Center in New York City administered a single dose of clindamycin to a group of mice and found surviving mice remained susceptible to C. difficile infection for at least 28 days, according to research published…